Esther Rajavelu

Stock Analyst at UBS

(0.68)
# 4,040
Out of 5,033 analysts
26
Total ratings
46.15%
Success rate
-22.85%
Average return

Stocks Rated by Esther Rajavelu

Ionis Pharmaceuticals
Aug 12, 2025
Maintains: Neutral
Price Target: $45$46
Current: $73.55
Upside: -37.46%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13$2
Current: $1.47
Upside: +36.05%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70$32
Current: $17.25
Upside: +85.51%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141$215
Current: $491.22
Upside: -56.23%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $34.40
Upside: +112.21%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108$109
Current: $17.54
Upside: +521.44%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $34.65
Upside: +1.01%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174$228
Current: $134.85
Upside: +69.08%
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $38.47
Upside: -
Innoviva
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $17.21
Upside: -24.46%
Initiates: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%